MedPath

四川新斯顿制药股份有限公司

Ownership
-
Established
1996-03-30
Employees
-
Market Cap
-
Website
http://www.bumaixin.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

23

NMPA:23

Drug Approvals

Piracetam Injection

Product Name
吡拉西坦注射液
Approval Number
国药准字H20254518
Approval Date
Jun 10, 2025
NMPA

Cobamamide Capsules

Product Name
腺苷钴胺胶囊
Approval Number
国药准字H20253704
Approval Date
Mar 25, 2025
NMPA

Ketorolac Trometamol Injection

Product Name
酮咯酸氨丁三醇注射液
Approval Number
国药准字H20253273
Approval Date
Jan 24, 2025
NMPA

Phloroglucinol Injection

Product Name
间苯三酚注射液
Approval Number
国药准字H20249150
Approval Date
Oct 22, 2024
NMPA

Urapidil Hydrochloride Injection

Product Name
盐酸乌拉地尔注射液
Approval Number
国药准字H20244547
Approval Date
Jul 30, 2024
NMPA

Mecobalamin Tablets

Product Name
甲钴胺片
Approval Number
国药准字H20244481
Approval Date
Jul 22, 2024
NMPA

Argatroban Injection

Product Name
阿加曲班注射液
Approval Number
国药准字H20244449
Approval Date
Jul 16, 2024
NMPA

Ornidazole Injection

Product Name
奥硝唑注射液
Approval Number
国药准字H20234750
Approval Date
Dec 29, 2023
NMPA

Ornidazole Injection

Product Name
奥硝唑注射液
Approval Number
国药准字H20234751
Approval Date
Dec 29, 2023
NMPA

Milrinone Injection

Product Name
米力农注射液
Approval Number
国药准字H20234638
Approval Date
Dec 13, 2023
NMPA
  • Prev
  • 1
  • 2
  • 3
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.